+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Research Report on China's Mecobalamin Market, 2021-2025

  • PDF Icon

    Report

  • 50 Pages
  • July 2021
  • Region: China
  • China Research & Intelligence
  • ID: 5393436
Mecobalamin is an endogenous coenzyme B12, which has a good effect on neuronal conduction compared with other types of vitamin B12, and can promote nucleic acid-protein-lipid metabolism through methyl conversion reaction. It is mainly used in clinical practice for peripheral neuropathy and megaloblastic anemia caused by vitamin B12 deficiency. In addition, Mecobalamin has been widely used in clinical practice to promote nerve anastomosis in reinserted fingers, promote sensory recovery, and improve neurological symptoms caused by disc herniation, sciatica, facial palsy, herpes zoster, etc.

Eisai's Mecobalamin, whose trade name is Methycocal, was approved to enter the Chinese market in 1998, followed by other companies' generic drugs. According to the market research, by 2020, there will be several suppliers in the mecobalamin market in China, with North China Pharmaceutical Company Limited as the main supplier.

According to the research data, the sales of Mecobalamin in the Chinese Market are relatively stable from 2016 to 2019. Due to the impact of the new covid-19 pandemic on the overall treatment services of hospitals, the sales of Mecobalamin in the Chinese Market declined to CNY529 million in 2020, with a CAGR of -3.44% from 2016 to 2020.

The analyst expects the sales volume of Mecobalamin in the Chinese Market to recover in 2021-2025 with the effective mitigation of the New covid-19 pandemic. Meanwhile, Eisai's Mecobalamin has been selected by the Chinese government for the third batch of volume procurement, and the sales volume is expected to rise significantly. With the improvement and popularization of medical services in China, the demand for Mecobalamin will continue to increase, and the sales volume of Mecobalamin in China will have some upside.

Key Points:

  • Impact of COVID-19 on China’s Mecobalamin Market
  • Development Environment of Mecobalamin in China
  • Sales Volume of Mecobalamin in China
  • Sales Volume and Sales Value of Mecobalamin in Different Regions of China
  • Major Mecobalamin Manufacturers in China and Their Market Shares
  • Market Prices of Mecobalamin in China
  • Major Mecobalamin Manufacturers in China
  • Prospect on China’s Mecobalamin Market, 2021-2025

Table of Contents

1 Related Concepts of Mecobalamin
1.1 Indications of Mecobalamin
1.2 Development History of Mecobalamin in the Chinese Market
1.3 Approval Information of Mecobalamin in China
1.4 Impact of COVID-19 on the Sales of Mecobalamin in the Chinese Market
2 Sales of Mecobalamin in the Chinese Market, 2016-2020
2.1 Sales Value of Mecobalamin
2.1.1 Sales Value in China Market
2.1.2 Sales Value in Different Regions of China
2.2 Sales Volume of Mecobalamin
2.2.1 Sales Volume in China
2.2.2 Sales Volume in Different Regions of China
2.3 Sales of Mecobalamin by Dosage Form in China, 2016-2020
2.3.1 Tablets
2.3.2 Injections
2.3.3 Capsules
3 Analysis of Major Mecobalamin Manufacturers of in China in 2020
3.1 Market Share Analysis of Major Mecobalamin Manufacturers
3.1.1 Market Share of Manufacturers by Sales Value
3.1.2 Market Share of Manufacturers by Sales Volume
3.2 North China Pharmaceutical Co., Ltd.
3.2.1 Company Profile
3.2.2 Sales of Yishenbao (Mecobalamin produced by North China Pharmaceutical Co., Ltd.) in China.
3.3 Eisai (China) Pharmaceutical Co., Ltd.
3.3.1 Company Profile
3.3.2 Sales of Methycocal (Mecobalamin produced by Eisai (China) Pharmaceutical Co., Ltd.) in China.
3.4 Yangtze River Pharmaceutical Group, Nanjing Hailing Pharmaceutical Co., Ltd.
3.4.1 Company Profile
3.4.2 Sales of Qixin (Mecobalamin produced by Hailing Pharmaceutical Co., Ltd.) in China.
3.5 Eisai Co., Ltd.
3.5.1 Company Profile
3.5.2 Sales of Methycocal (Mecobalamin produced by Eisai Co., Ltd.) in China.
3.6 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
3.6.1 Company Profile
3.6.2 Sales of Zhuohe (Mecobalamin produced by Jiangsu Sihuan Biopharmaceutical Co., Ltd.) in China
4 Major Manufacturers’ Mecobalamin Market Prices in China, 2020-2021
4.1 North China Pharmaceutical Co., Ltd. (Yishenbao)
4.2 Eisai (China) Pharmaceutical Co., Ltd. (Methycocal)
4.3 Yangtze River Pharmaceutical Group, Nanjing Hailing Pharmaceutical Co., Ltd. (Qixin)
4.4 Eisai Pharmaceutical Co., Ltd. (Methycocal)
4.5 Jiangsu Sihuan Biopharmaceutical Co., Ltd. (Zhuohe)
5 Prospect on China’s Mecobalamin Market, 2021-2025
5.1 Influencing Factors of the Development of China’s Mecobalamin Market, 2021-2025
5.1.1 Impact of COVID-19 on China’s Mecobalamin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Market Scale Forecast
5.3 Market Trend Forecast
Partial List of Charts
Chart: Approval Information of Mecobalamin Tablets in China
Chart: Approval information of mecobalamin Injection in China
Chart: Approval Information of Mecobalamin Capsules in China
Chart: Global Sales of Mecobalamin Tablets
Chart: Global Sales of Mecobalamin Injection
Chart: Global Sales of Mecobalamin Capsules
Chart: Sales Value of Mecobalamin Tablets in the Chinese Market, 2016-2020
Chart: Sales Value of mecobalamin Injection in the Chinese Market, 2016-2020
Chart: Sales Value of Mecobalamin Capsules in the Chinese Market, 2016-2020
Chart: Sales Value of Mecobalamin Tablets in Selected Regions of China,2016-2020
Chart: Sales Value of Mecobalamin Injection in Selected Regions of China, 2016-2020
Chart: Sales Value of Mecobalamin Capsules in Selected Regions in China, 2016-2020
Chart: Sales Volume of Mecobalamin Tablets in the Chinese Market, 2016-2020
Chart: Sales Volume of Mecobalamin Injection in the Chinese Market, 2016-2020
Chart: Sales Volume of Mecobalamin Capsules in the Chinese Market, 2016-2020
Chart: Sales Volume of Mecobalamin Tablets in Selected Regions of China, 2016-2020
Chart: Sales Volume of Mecobalamin Injection in Selected Regions of China, 2016-2020
Chart: Sales Volume of Mecobalamin Capsules in Selected Regions of China, 2016-2020
Chart: Sales Market Share of Mecobalamin Tablets Manufacturers in the Chinese Market, 2016-2020
Chart: Sales Market Share of Mecobalamin Injection Manufacturers in the Chinese Market, 2016-2020
Chart: Sales Market Share of Mecobalamin Capsules Manufacturers in the Chinese Market, 2016-2020
Chart: Sales Value and Sales Volume of Mecobalamin in the Chinese Market by North China Pharmaceutical Co., Ltd. 2016-2020
Chart: Sales Value and Sales Volume of Mecobalamin in the Chinese Market by Eisai (China) Pharmaceutical Co., Ltd. 2016-2020
Chart: Sales Value and Sales Volume of Mecobalamin in the Chinese Market by Yangtze River Pharmaceutical Group, Nanjing Hailing Pharmaceutical Co., Ltd. 2016-2020
Chart: Sales Value and Sales Volume of Mecobalamin in the Chinese Market by Eisai Pharmaceutical Co., Ltd. 2016-2020
Chart: Sales Value and Sales Volume of Mecobalamin in the Chinese Market by Jiangsu Sihuan Biopharmaceutical Co., Ltd. 2016-2020
Chart: Sales Prices of Mecobalamin Products of North China Pharmaceutical Co., Ltd. in Selected Regions of China, 2020-2021
Chart: Sales Prices of Mecobalamin Products of Eisai (China) Pharmaceutical Co., Ltd. in Selected Regions of China, 2020-2021
Chart: Sales Prices of Mecobalamin Products of Yangtze River Pharmaceutical Group, Nanjing Hailing Pharmaceutical Co., Ltd. in Selected Regions of China, 2020-2021
Chart: Sales Prices of Mecobalamin Products of Eisai Pharmaceutical Co., Ltd. in Selected Regions of China, 2020-2021
Chart: Sales Prices of Mecobalamin Products of Jiangsu Sihuan Biopharmaceutical Co., Ltd. in Selected Regions of China, 2020-2021
Chart: Forecast on Mecobalamin Tablets Sales Value in the Chinese Market, 2021-2025
Chart: Forecast on Mecobalamin Injection Sales Value in the Chinese Market, 2021-2025
Chart: Forecast on Mecobalamin Capsules Sales Value in the Chinese Market, 2021-2025
Chart: Forecast on Mecobalamin Tablets Sales Volume in the Chinese Market, 2021-2025
Chart: Forecast on Mecobalamin Injection Sales Volume in the Chinese Market, 2021-2025
Chart: Forecast on Mecobalamin Capsules Sales Volume in the Chinese Market, 2021-2025

Samples

Loading
LOADING...

Companies Mentioned

  • North China Pharmaceutical Co., Ltd. (Yishenbao)
  • Eisai (China) Pharmaceutical Co., Ltd. (Methycocal)
  • Yangtze River Pharmaceutical Group, Nanjing Hailing Pharmaceutical Co., Ltd. (Qixin)
  • Eisai Pharmaceutical Co., Ltd. (Methycocal)
  • Jiangsu Sihuan Biopharmaceutical Co., Ltd. (Zhuohe)

Methodology

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...

Table Information